NCT05544968 2026-01-12
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Phase 1 Not yet recruiting
Clinical Trials
1 trialsLymphoma, Large-Cell, Anaplastic × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all